David Wenkert is an Endocrinology/Metabolic physician affiliated with Scott & White Memorial Hospital. OpenAlex indexes 19 publications with 426 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 S 31st St
Temple, TX 765083496
Telephone
254-724-2111Provider last certified this registry record 25 Jan 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Globus Medical, Inc.Program year20251 payment
- Amgen Inc.Program year20231 payment
- Lilly USA, LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
39.3%Insulin Analog10.4%Lantus Solostar42%Humalog Kwikpen U-10018%Novolog Flexpen18%Tresiba Flextouch U-10010%Insulin Lispro Kwikpen U-1007%Basaglar Kwikpen U-1006%Part D<11 patientsGLP-1 receptor agonist10.1%Ozempic50%Mounjaro30%Trulicity20%Part D≥37 patients+ 5 more classes in this area
Hormonal (systemic)
33.3%l-Thyroxine30.3%Levothyroxine Sodium90%Synthroid10%Part D≥153 patientsThyroid Hormone Synthesis Inhibitor2.5%Methimazole100%Part D≥22 patients+ 1 more class in this area
Cardiovascular
23.3%Statin13%Atorvastatin Calcium59%Rosuvastatin Calcium19%Pravastatin Sodium15%Simvastatin8%Part D<11 patientsACE inhibitor4.2%Lisinopril87%Lisinopril-Hydrochlorothiazide13%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MON-412 Immune Thrombocytopenic Purpura Induced by Propylthiouracil: A Clinical Exploration
Journal of the Endocrine Society
2025 - Diabetic ketoacidosis outcomes and the “July effect”
Baylor University Medical Center Proceedings
2024 - The importance of recognition of comorbidities: Diabetic ketoacidosis and <i>Clostridioides difficile</i> infection
Baylor University Medical Center Proceedings
2024 - Progress toward the use of noninsulin antihyperglycemic medications in hospitalized patients
Baylor University Medical Center Proceedings
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Kimberly W. Coates
Scott & White Memorial Hospital
William Bryant, MD
Scott & White Memorial Hospital
Allan Nickel, MD
Scott & White Memorial Hospital
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”